Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY26.72 CNY
Change Today 0.00 / 0.00%
Volume 0.0
As of 3:05 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

shenzhen hepalink pharmace-a (002399) Snapshot

Open
--
Previous Close
CNY26.72
Day High
--
Day Low
--
52 Week High
06/3/15 - CNY48.98
52 Week Low
09/16/14 - CNY21.26
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
CNY0.62
Shares Outstanding
800.2M
EX-Date
06/9/15
P/E TM
--
Dividend
CNY0.30
Dividend Yield
1.12%
Current Stock Chart for SHENZHEN HEPALINK PHARMACE-A (002399)

Related News

No related news articles were found.

shenzhen hepalink pharmace-a (002399) Related Businessweek News

No Related Businessweek News Found

shenzhen hepalink pharmace-a (002399) Details

Shenzhen Hepalink Pharmaceutical Co., Ltd. researches and develops, produces, and sells heparin sodium API and heparin derivatives to pharmaceutical companies in China and internationally. The company was founded in 1998 and is based in Shenzhen, China.

Founded in 1998

shenzhen hepalink pharmace-a (002399) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shenzhen hepalink pharmace-a (002399) Key Developments

Shenzhen Hepalink Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Aug 27, 2015

Shenzhen Hepalink Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Aug 27, 2015., at 14:30 China Standard Time. Agenda: To consider the company's share repurchase plan within the quota of CNY 1 billion.

Hepalink Pharmaceutical Announces Earnings Results for the First Half of 2015

Hepalink Pharmaceutical announced earnings results for the first half of 2015. The company recorded net profits of CNY 275 million in the first half of this year, surging 150.28% year on year, and earnings per share were CNY 0.34. Operating income reached CNY 1.223 billion, growing 34.17% year on year.

Shenzhen Hepalink Pharmaceutical Co., Ltd. to Report Q1, 2016 Results on Jul 29, 2015

Shenzhen Hepalink Pharmaceutical Co., Ltd. announced that they will report Q1, 2016 results on Jul 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002399:CH CNY26.72 CNY 0.00

002399 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002399.
View Industry Companies
 

Industry Analysis

002399

Industry Average

Valuation 002399 Industry Range
Price/Earnings 41.8x
Price/Sales 9.3x
Price/Book 2.5x
Price/Cash Flow 41.2x
TEV/Sales 6.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHENZHEN HEPALINK PHARMACE-A, please visit www.hepalink.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.